Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1945 3
1946 4
1947 2
1949 1
1950 2
1951 2
1953 1
1954 2
1956 1
1957 3
1958 2
1961 3
1962 1
1963 2
1964 1
1968 1
1969 2
1970 3
1971 1
1972 4
1973 3
1974 1
1975 5
1976 6
1977 6
1978 15
1979 6
1980 12
1981 3
1982 5
1983 8
1984 3
1985 1
1986 12
1987 5
1988 4
1989 8
1990 9
1991 5
1992 5
1993 6
1994 6
1995 9
1996 5
1997 14
1998 12
1999 7
2000 11
2001 3
2002 11
2003 7
2004 10
2005 7
2006 6
2007 13
2008 3
2009 6
2010 3
2011 4
2012 5
2013 7
2014 10
2015 4
2016 5
2017 8
2018 7
2019 6
2020 16
2021 17
2022 14
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Results by year

Filters applied: . Clear all
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. Among authors: davey d. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Cardiovascular Safety of Testosterone-Replacement Therapy.
Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Lincoff AM, et al. Among authors: davey d. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16. N Engl J Med. 2023. PMID: 37326322 Clinical Trial.
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.
Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, Davey D, Dubcenco E, Fukumoto S, Garcia M, Granger CB, Kalahasti V, Khera M, Miller MG, Mitchell LM, O'Leary MP, Pencina KM, Snyder PJ, Thompson IM Jr, Travison TG, Wolski K, Nissen SE; TRAVERSE Study Investigators. Bhasin S, et al. Among authors: davey d. Am Heart J. 2022 Mar;245:41-50. doi: 10.1016/j.ahj.2021.11.016. Epub 2021 Dec 4. Am Heart J. 2022. PMID: 34871580 Free article. Clinical Trial.
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
Nicholls S, Lincoff AM, Bays HE, Cho L, Grobbee DE, Kastelein JJ, Libby P, Moriarty PM, Plutzky J, Ray KK, Thompson PD, Sasiela W, Mason D, McCluskey J, Davey D, Wolski K, Nissen SE. Nicholls S, et al. Among authors: davey d. Am Heart J. 2021 May;235:104-112. doi: 10.1016/j.ahj.2020.10.060. Epub 2020 Oct 24. Am Heart J. 2021. PMID: 33470195 Clinical Trial.
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Obeid S, Libby P, Husni E, Wang Q, Wisniewski LM, Davey DA, Wolski KE, Xia F, Bao W, Walker C, Ruschitzka F, Nissen SE, Lüscher TF. Obeid S, et al. Among authors: davey da. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3;8(6):611-621. doi: 10.1093/ehjcvp/pvac015. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35234840 Clinical Trial.
Parathyroid cytopathology.
Davey DD, Glant MD, Berger EK. Davey DD, et al. Diagn Cytopathol. 1986 Jan-Mar;2(1):76-80. doi: 10.1002/dc.2840020116. Diagn Cytopathol. 1986. PMID: 2424691
Kappa agonist CovX-Bodies.
Roberts LR, Brady K, Brown A, Davey D, Feng L, Huang H, Liu D, Malet L, McMurray G, Phelan A, Saunders K, Bhat A. Roberts LR, et al. Among authors: davey d. Bioorg Med Chem Lett. 2012 Jun 15;22(12):4173-8. doi: 10.1016/j.bmcl.2012.04.040. Epub 2012 Apr 25. Bioorg Med Chem Lett. 2012. PMID: 22583618
Future directions in cervical cytology.
Solomon D, Davey D, Nozawa S, Syrjänen KJ. Solomon D, et al. Among authors: davey d. Acta Cytol. 1998 Jan-Feb;42(1):1-4. doi: 10.1159/000331528. Acta Cytol. 1998. PMID: 9479318 No abstract available.
403 results